• Gifts that give back

    Gifts for the Cure are real and meaningful gifts that you give to your family, friends, and co-workers for any special occasion, while also making an impact to those affected by cancer.

    Shop Now

  • Breast Cancer Futures Fund

    Support the Breast Cancer Futures Fund and create a lasting change in women’s health.

    Learn More

  • You Are Not Alone

    Whether you are living with metastatic breast cancer or have a loved one who is, it can be helpful to talk with someone who understands what you are going through. We are available to you.

    Learn More

  • Canadian Cancer Statistics 2017

    Canadian Cancer Statistics 2017 was released on June 20. This annual publication gives detailed statistics for the most common types of cancer.

    Learn More

  • Questions related to breast cancer?

    Our team has the latest information about breast cancer and can answer questions about a diagnosis, treatments, what to expect, financial resources, coping, local support groups and more.

    Learn More

  • About Our Merger

    On February 1, 2017, the Canadian Cancer Society (CCS) and the Canadian Breast Cancer Foundation (CBCF) joined forces.

    Learn More

You Are Here :
Home | Central | About Us | Media Centre | Press Releases | Discovery of the new breast cancer susceptibility gene, RECQL, made possible in part by CBCF Funding

Upcoming Events

Hot Topics

Corporate Partners & Sponsors

Discovery of the new breast cancer susceptibility gene, RECQL, made possible in part by CBCF Funding

Published On 4/29/2015

Canadian Breast Cancer Foundation (CBCF) funded researcher Dr. Mohammad Akbari and his team of international researchers have identified a new breast cancer susceptibility gene, RECQL. 
Dr. Akbari was the lead researcher on this study, who in collaboration with Canadian and Polish researchers found a strong link between the mutations in the gene called RECQL and the onset of breast cancer in a sample of Polish and French-Canadian women.
The findings, published in the journal Nature Genetics, involved more than 25,000 women with and without breast cancer within the French-Canadian and Polish “founder” populations. The findings offer new insight into hereditary breast cancer.
The mutation of the RECQL gene itself is rare; however those with the mutated gene have a 50 per cent chance of developing breast cancer. This discovery has significant implications for prevention, diagnosis and treatment. It could lead to targeted treatments for this subset of breast cancer patients, and even help prevent cancer by giving those who know they have the mutation the option of prophylactic mastectomy.
CBCF continues to invest in the best and brightest minds, leading us closer to a future without breast cancer.